Free Republic
Browse · Search
General/Chat
Topics · Post Article

Skip to comments.

21 million Americans may take a hypothyroidism drug they don't need (90% don’t need levothyroxine (Synthroid))
Medical Xpress / Yale University / Clinical Chemistry ^ | April 6, 2023 | Isabella Backman / Joe M El-Khoury et al

Posted on 04/07/2023 11:15:04 PM PDT by ConservativeMind

As many as 90% of those who take levothyroxine [Synthroid] may have been unnecessarily prescribed the hypothyroidism medication.

Providers diagnose hypothyroidism by first measuring TSH levels in the blood. If the level is elevated, they will conduct a second test examining Free T4 levels. If TSH is high and Free T4 is low, the provider diagnoses the patient with hypothyroidism. Levothyroxine works by supplementing low hormone levels with exogenous T4.

Some patients, however, have mildly elevated TSH and normal Free T4. Providers diagnose this as subclinical hypothyroidism, and sometimes this is also treated with levothyroxine to lower TSH. This practice may do more harm than good. "Study after study has shown that there is greater risk when you overtreat with levothyroxine in patients who may not need it," says El-Khoury.

A 2021 study found that out of the 23 million Americans who are taking levothyroxine, approximately 21 million [~90%] likely don't need the prescription. Because levothyroxine can cause side effects including anxiety, heat intolerance, and diarrhea—and in extreme cases, cardiovascular morbidity and death, especially in those over 80—this finding is alarming, says El-Khoury.

According to El-Khoury, a major reason for inappropriate diagnoses is seasonal variation. Typically, TSH is higher in the winter. Because current screening measures do not consider the natural variation, many patients presenting with hypothyroidism-like symptoms are getting tested at a time when their TSH levels are naturally higher and being prescribed levothyroxine.

El-Khoury hopes to raise awareness about the extent of this problem and encourage providers to re-test their patients at least 3 months later before initiating levothyroxine treatment.

The assay used at Yale defines the normal limit for TSH as between 0.27 and 4.2 mIU/L. However, recent research suggests levothyroxine has no benefit in patients who initiate treatment when their levels are naturally under 7.0 mIU/L.

(Excerpt) Read more at medicalxpress.com ...


TOPICS: Health/Medicine
KEYWORDS: thyroid
Navigation: use the links below to view more comments.
first previous 1-2021-4041-42 last
To: RitaOK

Levothiroxone is generic synthroid.


41 posted on 04/08/2023 2:51:54 PM PDT by Chickensoup (Genocide is here. Leftist extremists are spearhheading the Genocide against conservatives. )
[ Post Reply | Private Reply | To 39 | View Replies]

To: ConservativeMind

Again, thanks.
BKMk


42 posted on 04/08/2023 7:22:49 PM PDT by Faith65 (Isaiah 40:31 )
[ Post Reply | Private Reply | To 1 | View Replies]


Navigation: use the links below to view more comments.
first previous 1-2021-4041-42 last

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
General/Chat
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson